Seo Yun Jo

CEO Seo Yun Jo, MD, Ph.D., is the Founder and Chief Executive Officer of JHK Medical Science Inc., founded in 2020. The company focuses on developing blood-based diagnostic solutions for neurodegenerative diseases, particularly Mild Cognitive Impairment (MCI) and Alzheimer’s disease, with an emphasis on early, accessible, and high precision detection. Under her leadership, JHK Medical Science Inc. is advancing proprietary biomarker based in vitro diagnostic technologies and progressing through clinical validation and regulatory pathways to support global commercialization. CEO Seo Yun Jo was awarded the Presidential Award at the 7th Government Public Data Utilization Startup Idea Competition in recognition of her contributions to healthcare innovation